Scribe Therapeutics cofounder and CEO Benjamin Oakes, PhD, joins a16z Bio + Health founding general partner Vijay Pande.
In this episode, Benjamin traces his journey from PhD student to pioneering CEO in genome editing. Benjamin discusses his early exposure to CRISPR technologies, his hands-on experience of transforming these bacterial immune systems into "genome editing scalpels," and the founding of Scribe. The conversation sheds light on the challenges of engineering these molecules, as well as the potential for life-changing therapeutics.
Journal Club: Restoring a Reflex
Sea Turtle Medicine
Journal Club: Assembling an Egg
The Art and Science of Biology's Future
Journal Club: Engineering Living Materials
Value Versus Volume (in Healthcare)
Things That Make You Go Hmmmm in Healthcare
Journal Club: My Tick Teacher
May I Have Your Insurance Card Again, Please?
Journal Club: Suppressing Superbugs
From Junk DNA to an RNA Revolution
Journal Club: Slaying the Sleeper Cells of Aging
The Fundamental Principles of Reality
Journal Club: A Safer Psychedelic
The Genetics of Risk
Journal Club: Synthetic Germs, Our Newest Weapon for Fighting Cancer
The Biology of Brain Organoids (or, Don't Call it a Brain in a Dish!)
Journal Club: Why do only some people get severe COVID-19?
So You Wanna Build a Software Company in Healthcare?
The Machine That Made the Vaccine
Create your
podcast in
minutes
It is Free